Nessun prodotto nella lista dei desideri.
61,68 €
ARIMIPLEX® PCT is a groundbreaking Post Cycle Therapy product that boosts testosterone levels, blocks estrogen, and supports overall hea
ARIMIPLEX® PCT is a premier dietary supplement from Hi-Tech Pharmaceuticals, specifically designed for Terapia post ciclo (PCT). This product combines six essential components, significantly advancing the field of legal post cycle therapy and establishing itself as one of the most powerful solutions available. The carefully engineered formula aims to restore testosterone levels, improve energy, strength, and libido while providing crucial support to various body systems during the recovery phase after a prohormone cycle.
Blocks Estrogen: ARIMIPLEX® PCT contains a potent anti-estrogen component, specifically Arimistane (Androst 3,5-dien-7,17-dione), which acts as a suicide inhibitor. It reduces excess estrogen production and helps lower existing estrogen levels, helping to maintain hormonal balance.
Supports Cardiovascular Health: With the integration of specific compounds, the formula promotes cardiovascular function, ensuring heart health during the hormonal adjustments of post-cycle recovery.
Elevates Testosterone Levels: By stimulating the production of both free and total testosterone, ARIMIPLEX® PCT plays a critical role in revitalizing testosterone levels after an anabolic cycle.
Restores Liver Enzymes: The product includes ingredients that encourage liver regeneration and detoxification, vital for the body’s recovery from previous cycles.
Supports and Protects the Prostate: ARIMIPLEX® PCT contains components aimed at prostate health, an essential aspect when dealing with hormonal adjustments.
Revitalizes Energy Levels and Enhances Libido: Users can expect improvements in overall energy and sexual performance, addressing common post-cycle issues related to testosterone depletion.
Integrazione Cyclosome™ Technology, ARIMIPLEX® PCT enhances the bioavailability of its active ingredients by encapsulating them within a complex that allows for improved absorption and efficacy. This technology is critical in ensuring the active compounds bypass the liver’s first-pass metabolism, maximizing their potency and effectiveness.
Per risultati ottimali, si consiglia di assumere one tablet in the morning and one in the evening, thereby not exceeding the suggested dose of two tablets per day. This regimen is designed to provide consistent support for testosterone and overall health during the post-cycle recovery phase.
While the specific formulation may vary, key ingredients in ARIMIPLEX® PCT typically include:
Arimistane (Androst 3,5-dien-7,17-dione): An effective aromatase inhibitor that decreases estrogen levels by permanently binding to the aromatase enzyme.
Liver support ingredients such as Milk Thistle (standardized to contain 80% Silymarin): Known for its hepatoprotective effects, aiding liver function during the detoxification process.
Anterior Pituitary Peptides: Enhance Luteinizing Hormone (LH) levels to support testosterone production post-cycle.
Anti-estrogen agent and additional herbal extracts: Formulate the adjunctive support system that addresses potential post-cycle hormonal imbalances.
ARIMIPLEX® PCT stands out in the realm of post-cycle therapies by not only addressing testosterone recovery but also enhancing overall bodily functions during a critical transition period. Utilizing a sophisticated formulation backed by innovative delivery technology, this product represents a significant leap forward in post-cycle support and hormonal balance maintenance. It is essential to follow the recommended dosage for the best results while being aware that these statements have not been evaluated by the Food and Drug Administration, and the product is not intended to diagnose, treat, cure, or prevent any disease.
Ecco un elenco di referenze scientifiche per gli ingredienti menzionati nella descrizione di ARIMIPLEX® PCT:
Shi, G., & Zhang, W. (2021). “Aromatase inhibitors: The role of androstenedione derivatives in the treatment of hormonal imbalances”. Current Pharmacological Reports.
Silymarin (Milk Thistle):
Loguercio, C., & de Simone, T. (2007). “Silymarin and liver diseases”. Progettazione farmaceutica attuale, 13(34), 3495-3502.
Testosterone:
McCullough, A. (2018). “The Role of Testosterone in Men’s Health”. American Family Physician, 98(11), 659-664.
Ormone luteinizzante (LH):
Kahn, B. L., & Rinehart, J. (2021). “Changes in Luteinizing Hormone Levels during Hormonal Treatment.” Rivista di endocrinologia, 248(1), R13-R26.
Cyclosome Technology:
Recensioni
Non ci sono ancora recensioni.